Your session is about to expire
← Back to Search
Contact Lens
Evaluation of Etafilcon A Daily Disposable Lenses
N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-week follow-up
Awards & highlights
No Placebo-Only Group
Summary
To evaluate the clinical performance of daily disposable etafilcon A lenses.
Eligible Conditions
- Near-sightedness
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-week follow-up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-week follow-up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Monocular Logarithm of the Minimum Angle of Resolution (logMAR) Visual Acuity - Standard High Contrast Dim
Monocular logMar Visual Acuity - Standard Low Contrast Bright
Overall Comfort
+1 moreSide effects data
From 2014 Phase 1 & 2 trial • 289 Patients • NCT0143731910%
Cornea Lens Peripheral Ulcer (CLPU)
10%
Conjunctivitis
5%
Asymptomatic corneal scar
100%
80%
60%
40%
20%
0%
Study treatment Arm
Comfilcon A
Balafilcon A
Lotrafilcon A
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Etafilcon A Test LensExperimental Treatment1 Intervention
etafilcon A
Group II: Etafilcon A Control LensActive Control1 Intervention
etafilcon A
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
etafilcon A
2008
Completed Phase 2
~2620
Find a Location
Who is running the clinical trial?
Johnson & Johnson Vision Care, Inc.Lead Sponsor
219 Previous Clinical Trials
25,655 Total Patients Enrolled